Be part of the future
The Yacoub Heart Valve®
What if your body could grow a new organ when one fails?
Meet Our Visionary Founder
After 30 years of groundbreaking scientific pursuit, Sir Magdi Yacoub has finally cracked it—the astonishing power to regrow new tissue and transform diseased hearts.
A professor of Cardiothoracic Surgery at Imperial College London, Sir Magdi founded the Magdi Yacoub Institute at Harefield Heart Science Centre, where he pioneered the world’s largest heart and lung transplantation program. With more than 1,400 published papers and prestigious honours including a Knighthood and the Order of Merit, his revolutionary research into tissue engineering is now paving the way for life-changing treatments that once seemed impossible.
Patient Outcomes
Why compromise?
No need for ongoing medication and monitoring
Restores full life expectancy
Grows with children, adapts with adults
A natural, living tissue valve that lasts a lifetime
Our vision
A world where every cardiovascular patient, adult or child, can trust in a restorative valve implant that lives, grows and learns with them; enabling their bodies to rebuild what nature intended – providing a future free from compromise.
Our mission
Restoring hope
Once should be enough
The challenge for children
Open heart surgery every 2-3 years?
Current valve protheses do not grow with children so children with heart disease are forced through multiple, risky, open heart procedures.
The Yacoub Valve®
The promise of “one and done”, a new living valve that grows with the child is within reach.
Revolutionising heart disease treatment through pioneering biotech solutions
FAQ
Find answers to commonly asked questions
Our unique, patented heart valve scaffold enables each patient’s own body to build its own living valve from its own cells
Tissue engineering heart valves have many advantages over traditional replacement valves. They promise to be more durable and grow with the patient, reduce life-long medications and restore full life expectancy
Our heart valve scaffold is being designed first for pulmonary valve replacement surgeries. We are extending our proprietary platform technology to address other types of heart valve replacements, soft tissue repair and more…
The Yacoub Heart Valve® is gradually replaced by the patient’s own cells over the first year in the body, ultimately becoming a brand new, living valve.
In-situ tissue-engineering promises to change everything in surgery. First colonised with the patient’s own stem cells, the scaffold then dissolves, leaving the patient with a natural replacement that their own body has produced, which will grow and adapt with them.
You can follow our page on LinkedIn and visit our website for updates about our journey, or contact us directly. We would be happy to try and answer any questions you may have.
At Heart Biotech Nano, we are dedicated to pushing the boundaries of what is possible in in-situ tissue engineering and biotechnology. Our team of experts have developed a proprietary platform that has potential to impact many clinical areas.
Yes, we are open to discussing potential investment opportunities. Please contact us using the above contact form above to learn more.